Skip to content
10-Q

Quarterly Report

VIKING THERAPEUTICS, INC. VKTX

0001193125-25-247059

← back to feed
Filed
Oct 23, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 15, 2025 113.04M sh
Shares Diluted Q3 2025 · Sep 30, 2025 112.32M sh
Shares Diluted Q3 2025 · Sep 30, 2025 112.22M sh
Shares Diluted Q3 2025 · Sep 30, 2024 110.91M sh
Shares Diluted Q3 2025 · Sep 30, 2024 108.26M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$193.4M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$56.61M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $100.38M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $26.68M
Stockholders Equity Q3 2025 · Sep 30, 2025 $713.03M
Stockholders Equity Q3 2025 · Dec 31, 2024 $880.28M
Current Liabilities Q3 2025 · Sep 30, 2025 $26.07M
Current Liabilities Q3 2025 · Dec 31, 2024 $27.41M
Total Liabilities Q3 2025 · Sep 30, 2025 $26.39M
Total Liabilities Q3 2025 · Dec 31, 2024 $28.04M
Current Assets Q3 2025 · Sep 30, 2025 $738.7M
Current Assets Q3 2025 · Dec 31, 2024 $907.22M
Total Assets Q3 2025 · Sep 30, 2025 $739.42M
Total Assets Q3 2025 · Dec 31, 2024 $908.32M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.81
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.80
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.22
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.69
Eps Basic Q3 2025 · Sep 30, 2025 −$0.81
Eps Basic Q3 2025 · Sep 30, 2025 −$1.80
Eps Basic Q3 2025 · Sep 30, 2024 −$0.22
Eps Basic Q3 2025 · Sep 30, 2024 −$0.69
Sga Expense Q3 2025 · Sep 30, 2025 $8.61M
Sga Expense Q3 2025 · Sep 30, 2025 $37.11M
Sga Expense Q3 2025 · Sep 30, 2024 $13.77M
Sga Expense Q3 2025 · Sep 30, 2024 $34.03M
Rd Expense Q3 2025 · Sep 30, 2025 $89.95M
Rd Expense Q3 2025 · Sep 30, 2025 $191.5M
Rd Expense Q3 2025 · Sep 30, 2024 $22.79M
Rd Expense Q3 2025 · Sep 30, 2024 $70.66M
Net Income Q3 2025 · Sep 30, 2025 −$90.79M
Net Income Q3 2025 · Sep 30, 2025 −$201.98M
Net Income Q3 2025 · Sep 30, 2024 −$24.94M
Net Income Q3 2025 · Sep 30, 2024 −$74.55M
Operating Income Q3 2025 · Sep 30, 2025 −$98.56M
Operating Income Q3 2025 · Sep 30, 2025 −$228.6M
Operating Income Q3 2025 · Sep 30, 2024 −$36.56M
Operating Income Q3 2025 · Sep 30, 2024 −$104.68M
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $0